Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Innate Pharma CEO Mondher Mahjoubi To Depart In January 2024; Co-Founder Hervé Brailly Appointed Interim CEO

Author: Benzinga Newsdesk | December 18, 2023 03:10am

Current CEO Mondher Mahjoubi to leave Innate Pharma to pursue an opportunity at a large pharmaceutical company
Current Chairman of the Supervisory Board, former CEO and company co-founder Hervé Brailly appointed interim CEO
Irina Staatz-Granzer, current Vice-Chairwoman of Supervisory Board, appointed Chairwoman of the Supervisory Board

Posted In: IPHA